tiprankstipranks
Trending News
More News >
Novartis AG (GB:0QLR)
LSE:0QLR

Novartis AG (0QLR) Stock Statistics & Valuation Metrics

Compare
11 Followers

Total Valuation

Novartis AG has a market cap or net worth of CHF171.67B. The enterprise value is CHF193.96B.
Market CapCHF171.67B
Enterprise ValueCHF193.96B

Share Statistics

Novartis AG has 2.11B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2.11B
Owned by Insiders
Owned by Instutions<0.01%

Financial Efficiency

Novartis AG’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.
Return on Equity (ROE)27.11%
Return on Assets (ROA)11.68%
Return on Invested Capital (ROIC)15.55%
Return on Capital Employed (ROCE)19.77%
Revenue Per EmployeeCHF681,601.94
Profits Per EmployeeCHF157,360.674
Employee Count75,883
Asset Turnover0.51
Inventory Turnover2.24

Valuation Ratios

The current PE Ratio of Novartis AG is 16.46. Novartis AG’s PEG ratio is -0.99.
PE Ratio16.46
PS Ratio3.80
PB Ratio4.46
Price to Fair Value4.46
Price to FCF14.23
Price to Operating Cash Flow11.15
PEG Ratio-0.99

Income Statement

In the last 12 months, Novartis AG had revenue of CHF51.72B and earned CHF11.94B in profits. Earnings per share was CHF5.89.
RevenueCHF51.72B
Gross ProfitCHF38.90B
Operating IncomeCHF14.54B
Pretax IncomeCHF13.64B
Net IncomeCHF11.94B
EBITDA20.71B
Earnings Per Share (EPS)5.89

Cash Flow

In the last 12 months, operating cash flow was CHF17.62B and capital expenditures -CHF3.81B, giving a free cash flow of CHF13.80B billion.
Operating Cash FlowCHF17.62B
Free Cash FlowCHF13.80B
Free Cash Flow per ShareCHF6.54

Dividends & Yields

Novartis AG pays an annual dividend of CHF3.50, resulting in a dividend yield of 3.88%
Dividend Per ShareCHF3.50
Dividend Yield3.88%
Payout Ratio54.78%
Free Cash Flow Yield7.03%
Earnings Yield6.08%

Stock Price Statistics

Beta0.65
52-Week Price Change9.83%
50-Day Moving Average94.75
200-Day Moving Average92.60
Relative Strength Index (RSI)44.64
Average Volume (3m)1.32M

Important Dates

Novartis AG upcoming earnings date is Apr 29, 2025, TBA.
Last Earnings DateJan 31, 2025
Next Earnings DateApr 29, 2025
Ex-Dividend DateMar 11, 2025

Financial Position

Novartis AG as a current ratio of 1.04, with Debt / Equity ratio of 0.71
Current Ratio1.04
Quick Ratio0.84
Debt to Market Cap0.15
Net Debt to EBITDA0.96
Interest Coverage Ratio14.46

Taxes

In the past 12 months, Novartis AG has paid CHF1.70B in taxes.
Income TaxCHF1.70B
Effective Tax Rate12.47%

Enterprise Valuation

Novartis AG EV to EBITDA ratio is 10.44, with an EV/FCF ratio of 15.67.
EV to Sales4.18
EV to EBITDA10.44
EV to Free Cash Flow15.67
EV to Operating Cash Flow12.28

Balance Sheet

Novartis AG has CHF13.35B in cash and marketable securities with CHF31.26B in debt, giving a net cash position of CHF17.91B billion.
Cash & Marketable SecuritiesCHF13.35B
Total DebtCHF31.26B
Net CashCHF17.91B
Net Cash Per ShareCHF8.48
Tangible Book Value Per Share-CHF3.75

Margins

Gross margin is 75.20%, with operating margin of 28.12%, and net profit margin of 23.09%.
Gross Margin75.20%
Operating Margin28.12%
Pretax Margin26.37%
Net Profit Margin23.09%
EBITDA Margin40.05%
EBIT Margin28.32%

Analyst Forecast

The average price target for Novartis AG is CHF101.38, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetCHF101.38
Price Target Upside12.67%
Analyst ConsensusHold
Analyst Count14
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis